tmprss2 activating protease (ATCC)
Structured Review

Tmprss2 Activating Protease, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 9095 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tmprss2+activating+protease/A549/pmc11892322-248-16-32
Average 99 stars, based on 9095 article reviews
Images
1) Product Images from "A bivalent spike-targeting nanobody with anti-sarbecovirus activity"
Article Title: A bivalent spike-targeting nanobody with anti-sarbecovirus activity
Journal: Journal of Nanobiotechnology
doi: 10.1186/s12951-025-03243-y
Figure Legend Snippet: Monovalent and bivalent 7F constructs neutralize authentic SARS-CoV-2 in A549 cells and HAE cell cultures and authentic SARS-CoV in Vero cells. A . Neutralization of SARS-CoV-2 in A549 ACE2+TMPRSS2+ cells. Virus was pre-incubated with serial diluted nanobody, or 10 µM remdesivir, for 30 min before infecting A549 ACE2+TMPRSS2+ cells. Infection was quantified by measuring the virus yield (viral RNA copies/ml, as determined with RT-qPCR) in cell culture supernatants of SARS-CoV-2 infected cells. B . Neutralization of SARS-CoV-2 in HAE cell culture. HAE cultures were incubated with SARS-CoV-2 and 100 nM nanobodies or 10 µM remdesivir on the apical side for 2 h. Nanobody incubation was repeated every 24 h. Graph showing the quantification of viral replication in the cultures, evaluated by RT-qPCR. C . Neutralization of SARS-CoV in Vero cells. Virus was pre-incubated with serial diluted nanobody, or 10 µM remdesivir, for 30 min before infecting Vero cells. Infection was quantified by measuring the virus yield (viral RNA copies/ml, as determined with RT-qPCR) in cell culture supernatants of SARS-CoV infected cells
Techniques Used: Construct, Neutralization, Virus, Incubation, Infection, Quantitative RT-PCR, Cell Culture
Related Articles
Expressing:Article Title: A bivalent spike-targeting nanobody with anti-sarbecovirus activity Article Snippet: .. A549 cells ( Homo sapiens , lung carcinoma, ATCC CCL-185) expressing human ACE2 receptor protein and Modification:Article Title: A bivalent spike-targeting nanobody with anti-sarbecovirus activity Article Snippet: .. A549 cells ( Homo sapiens , lung carcinoma, ATCC CCL-185) expressing human ACE2 receptor protein and |
